The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells

Tumor Biology

Volumn 36, Issue 2, 2015, Pages 959-966

  Weng, Mingzhe ^a   Song, Fangbin ^a   Chen, Jinyu ^a   Wu, Junyi ^a   Qin, Jun ^a   Jin, Tao ^a   Xu, Junming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Breast cancer; High mobility group nucleosome binding domain 5; Invasion; Proliferation

Indexed keywords

CASPASE 3; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE B; HIGH MOBILITY GROUP NUCLEOSOME BINDING DOMAIN 5; HIGH MOBILITY GROUP PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; HIGH MOBILITY GROUP N PROTEIN; HMGN5 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIVITY; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HMGN PROTEINS; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; TRANS-ACTIVATORS;

EID: 84923764446     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2715-1     Document Type: Article

References (38)

1. Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, et al. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Breast Cancer Res Treat. 2012;134:989–1004.
2. Caplan L. Delay in breast cancer: implications for stage at diagnosis and survival. Front Publ Health. 2014;2:87.
3. Gill M, McCarthy M, Murrells T, Silcocks P. Chemotherapy for the primary treatment of osteosarcoma: population effectiveness over 20 years. Lancet. 1988;1:689–92.
4. Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol. 1996;54:35–100.
5. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999;19:5237–46.
6. Rattner BP, Yusufzai T, Kadonaga JT. HMGN proteins act in opposition to ATP-dependent chromatin remodeling factors to restrict nucleosome mobility. Mol Cell. 2009;34:620–6.
7. Birger Y, West KL, Postnikov YV, Lim JH, Furusawa T, Wagner JP, et al. Chromosomal protein hmgn1 enhances the rate of DNA repair in chromatin. EMBO J. 2003;22:1665–75.
8. Birger Y, Catez F, Furusawa T, Lim JH, Prymakowska-Bosak M, West KL, et al. Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein hmgn1. Cancer Res. 2005;65:6711–8.
9. Zhou X, Yuan B, Yuan W, Wang C, Gao R, Wang J. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma. Tumour Biol. 2014;35:6539–47.
10. Huang C, Zhou LQ, Song G. Effect of nucleosomal binding protein 1 in androgen-independent prostatic carcinoma. Zhonghua Yi Xue Za Zhi. 2008;88:657–60.
11. Green J, Ikram M, Vyas J, Patel N, Proby CM, Ghali L, et al. Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours. Br J Cancer. 2006;94:1446–51.
12. Tang WY, Newbold R, Mardilovich K, Jefferson W, Cheng RY, Medvedovic M, et al. Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology. 2008;149:5922–31.
13. Wahafu W, He ZS, Zhang XY, Zhang CJ, Yao K, Hao H, et al. The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells. Tumour Biol. 2011;32:931–9.
14. Ji SQ, Yao L, Zhang XY, Li XS, Zhou LQ. Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo. J Exp Clin Cancer Res. 2012;31:22.
15. Rochman M, Malicet C, Bustin M. Hmgn5/nsbp1: a new member of the hmgn protein family that affects chromatin structure and function. Biochim Biophys Acta. 2010;1799:86–92.
16. Wang L, Zhang H, Qian J, Wang K, Zhu J. Interleukin-10 blocks in vitro replication of human cytomegalovirus by inhibiting the virus-induced autophagy in MRC5 cells. Biochem Biophys Res Commun. 2014;448:448–53.
17. Yang C, Gao R, Wang J, Yuan W, Wang C, Zhou X. High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy. Tumour Biol. 2014;35:6357–63.
18. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342–8.
19. Ye L, Bokobza S, Li J, Moazzam M, Chen J, Mansel RE, et al. Bone morphogenetic protein-10 (BMP-10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer. Cancer Sci. 2010;101:2137–44.
20. Jang SY, Kim A, Kim JK, Kim C, Cho YH, Kim JH, et al. Metformin inhibits tumor cell migration via down-regulation of MMP9 in tamoxifen-resistant breast cancer cells. Anticancer Res. 2014;34:4127–34.
21. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741–52.
22. Thorburn A. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis. 2008;13:1–9.
23. Hock R, Furusawa T, Ueda T, Bustin M. Hmg chromosomal proteins in development and disease. Trends Cell Biol. 2007;17:72–9.
24. Qu J, Yan R, Chen J, Xu T, Zhou J, Wang M, et al. HMGN5: a potential oncogene in gliomas. J Neurooncol. 2011;104:729–36.
25. Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, et al. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Eur J Cancer. 2006;42:3274–86.
26. Pritsker M, Ford NR, Jenq HT, Lemischka IR. Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc Natl Acad Sci U S A. 2006;103:6946–51.
27. Stoetzer OJ, Fersching DM, Salat C, Steinkohl O, Gabka CJ, Hamann U, et al. Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy. Tumour Biol. 2013;34:81–90.
28. Brezniceanu ML, Volp K, Bosser S, Solbach C, Lichter P, Joos S, et al. Hmgb1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J. 2003;17:1295–7.
29. He Q, Liang CH, Lippard SJ. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci U S A. 2000;97:5768–72.
30. Casimiro S, Luis I, Fernandes A, Pires R, Pinto A, Gouveia AG, et al. Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors. Clin Exp Metastasis. 2012;29:155–64.
31. Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li YQ, et al. Estrogen receptor alpha mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway. FEBS J. 2014;281:927–42.
32. Hafeez F, Neboori HJ, Harigopal M, Wu H, Haffty BG, Yang Q, et al. Is Ki-67 expression prognostic for local relapse in early-stage breast cancer patients treated with breast conservation therapy (BCT)? Int J Radiat Oncol Biol Phys. 2013;87:344–8.
33. Fan SH, Wang YY, Lu J, Zheng YL, Wu DM, Zhang ZF, et al. CERS2 suppresses tumor cell invasion and is associated with decreased v-ATPase and MMP-2/MMP-9 activities in breast cancer. J Cell Biochem. 2014, in press.
34. Li L, Wang Y, Qi B, Yuan D, Dong S, Guo D, Zhang C, Yu M. Suppression of PMA-induced tumor cell invasion and migration by ginsenoside Rg1 via the inhibition of NF-κB-dependent MMP-9 expression. Oncol Rep. 2014, in press.
35. Zhou R, Xu L, Ye M, Liao M, Du H, Chen H. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways. Horm Metab Res. 2014, in press.
36. Tong J, Yin S, Dong Y, Guo X, Fan L, Ye M, et al. Pseudolaric acid b induces caspase-dependent apoptosis and autophagic cell death in prostate cancer cells. Phytother Res. 2013;27:885–91.
37. Ren SX, Shen J, Cheng AS, Lu L, Chan RL, Li ZJ, et al. FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS One. 2013;8:e63641.
38. Yang YH, Li B, Zheng XF, Cheng JW, Chen K, Jiang SD, et al. Oxidative damage to osteoblasts can be alleviated by early autophagy through the endoplasmic reticulum stress pathway-implications for the treatment of osteoporosis. Free Radic Biol Med. 2014, in press